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1. Introduction 
It has been reported that phospholipase C from 
Oostridium welchii induces aggregation and release 
reaction of human blood platelets [l-3]. During 
these processes, the diacylglycerols generated in the 
platelet membrane are phosphorylated into phos- 
phatidic acids [4]. Similar changes occur in platelets 
activated by physiological agents [4-71 and in many 
other stimulated cells (reviewed in [8]). According to 
[8], this ‘phospholipid effect’ might be due to the 
activation of a PI-phosphodiesterase (phospholipase C) 
leading to an increased turnover of PI. We report 
here the presence of such an enzyme in human platelet 
cytosol and describe some of its properties. 
2. Experimental 
2.1. Substrate preparation 
32P-labelled PI was isolated from baker’s yeast 
grown in the presence of 32P-orthophosphate (CEA, 
Gif sur Yvette, France) [9]. Lipids were extracted as 
in [9], a PI-rich fraction was precipitated by 
propanol-2 [lo] and was further purified by thin- 
layer chromatography [ 111. The PI (spec. act. 
-1200 dpm/nmol) was chromatographically pure 
[ 121 and devoid of any ninhydrin-positive material. 
Non-labelled PI was prepared in the same way and 
was deacylated with Crotalus adamanteus phospho- 
lipase A2 [ 131. The lysophosphatidylinositol was 
reacylated with [5,6,8,9,11,12,14,15(n)-3H]- 
Abbreviation: PI, phosphatidylinositol 
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arachidonic acid (Radiochemical Centre, Amersham) 
using rat liver microsomes [ 141. The 1 -acyl, 
[2-3H]arachidonoyl-PI (spec. act. -600 dpm/nmol) 
was purified as above. 
2.2. Enzyme preparation 
Human blood platelets were prepared according to 
[ 151 and finally suspended in 0.025 M Tris~~maleate- 
NaOH buffer (pH 6.0) containing 0.125 M KCl. 
Platelet count was adjusted to 2 X lo9 cells/ml and 
microscopic observation showed no contamination 
by other blood cells. Platelets were lysed by sonica- 
tion (3 times, 10 s) using an MSE sonifier at maxi- 
mum output. The lysates were kept at 0-4°C or cen- 
trifuged at 105 000 X g for 60 min at 4°C in order to 
obtain a particulate fraction and a soluble supernatant . 
2.3. Incubation procedures 
Appropriate amounts of labelled PI were evaporated 
to dryness under nitrogen and sonicated in water just 
prior to use. The standard incubation medium contained 
in 0.5 ml : 200 nmol substrate, Tris-maleate- -NaOH 
buffer (final cont. 0.0125 M, pH 6.0) and 0.1 ml of 
the enzyme preparation. After 5 min at 37”C, the 
reactions were stopped by adding 1.9 ml chloroform/ 
methanol, l/2 (v/v) and partitioned as in [ 161. 
2.4. Analysis of incubation products 
Upper aqueous phase was routinely counted for 
total radioactivity. Identification of the hydrosoluble 
products was performed by thin-layer chromatography 
[ 171 before and after acidic hydrolysis [ 181. In the 
incubations performed with [2-3H]arachidonoyl-PI, 
the lower organic phases were analysed by thin-layer 
chromatography [ 191, 
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2.5 . Standards 
A mixture of inositol-1 -phosphate and inositol- 
1,2-cyclic phosphate was prepared from 32P-labelled 
PI using a crude phospholipase C from Bacillus cereus 
(Sigma, St Louis, MO). Glycerylphosphorylinositol 
was obtained by alkaline hydrolysis [20] and lyso- 
phosphatidylinositol as described above. Lipid stan- 
dards are currently available from our laboratory. 
2.6. Calcium concentration 
Ionized Ca*+ concentration was adjusted with 
Ca-EGTA buffer [21], taking in account the amounts 
of endogenous Ca*+, which were determined in platelet 
extracts as in [22]. 
3. Results 
3 .I . Identijication ofplatelet phospholipase CactivitJi 
Upon incubation with 32P-labelled PI, platelet 
lysates released 2 hydrosoluble radioactivity com- 
pounds. These had the same chromatographic behaviour 
as inositol-1 -phosphate and inositol-1,2-cyclic phos- 
phate (RF 0.22 and 0.52, respectively) and were 
separated from glycerylphosphorylinositol and lyso- 
phosphatidylinositol standards (RF 0.42 and 0.81, 
respectively). Furthermore, upon acidic hydrolysis, 
only inositol monophosphate was detected on the 
chromatograms of the assays, whereas the glyceryl- 
phosphorylinositol and lysophosphatidylinositol 
standards remained unchanged. On the other hand, 
incubation of [2-3H]arachidonoyl-PI led to the 
appearance of radioactive diacylglycerols. This indi- 
cates that platelets contain a typical phosphatidyl- 
inositol phosphodiesterase. 
3.2.Subcellulardistribution ofplatelet phospholipase C 
When measured under optimal conditions of pH 
and substrate concentration (see below), 90% of the 
total phospholipase C activity was found in the 
soluble supernatant. Noteworthy, the sum of enzyme 
activity recovered in both soluble and particulate frac- 
tions represented lOO-105% of the lysate activity 
(spec. act. 1 S-20 nmol/min/109 cells). 
3.3. Properties of the phospholipase Cactivity 
3.3 .I. Influence of pH 
Maximal hydrolysis was measured with little varia- 
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tion at pH 6.0-7.0, the optimal conditions being 
obtained at pH 6.0 (fig.]). 
3.3.2. Time course of PI hydrolysis 
As shown in fig.2, PI hydrolysis was linear for at 
least 5 min and the ratio inositol-l-phosphate/inositol- 
1,2-cyclic-phosphate remained constant during the 
incubation. 
3.3.3. Influence of substrate concentration 
No hydrolysis was detectable at < 0.040 mM PI 
(fig.3). However, this limit-value is 20-times higher 
than critical micellar concentration of PI (measured 
under our incubation conditions). Phospholipase C 
activity increased rapidly afterwards and reached a 
plateau at > 0.200 mM substrate. No significant 
inhibition by substrate excess was observed until 
2 mM PI. 
3.3.4. Influence of divalent cations 
The phospholipase C activity could be determined 
without any added divalent cation. However, it must 
t 
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Fig.1. pF1 dependence of platelet phospholipase C. PI was 
incubated with platelet lysates under standard incubation 
condiiions, each pH being adjusted using Tris-maleate- 
NaOH buffer. 
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Fig.2. Time course of Pi hydrolysis. Ordinates represent the 
amounts of hydrosoluble compounds r&eased under standard 
incubation conditions, using 0.2 X lo9 celis: total hydro- 
soluble compounds (A--A); inositol-1,2-cyclic phosphate 
(o----o);inositol-l-phosphate (*--•). 
be emphasized that such divalent cations were present 
in the platelet extracts. For instance, Ca” in the incu- 
bation medium as 0.3 X lOA M and 0.8 X lO+ M 
when using soluble s~pernata~t or total lysate, 
respectively. The addition of 2 mM EDTA inhibited 
the enzyme by 70%. This inhibition was overcome by 
2 mM CaC12, while MgCIZ was inefficient up to 
5 mM. As shown in fig.4, the phospholipase C activity 
increased in a range of calculated [Ca2*] free from 
10-6-10-3 M. Optimal Ca2+ concentrations were 
3X 104Mand8X 10-3Mwhenusing0.2mM 
and 0.4 mM PI, respectively. In both cases, a dramatic 
inhibition occurred at higher Ca2” concentration. 
Fig.3.Variation of PI hydrolysis with substrate concentration. 
Fig.4. Influence of [Caz’]free on phospholipasc C activity. 
Platelet lysates were incubated at varying [Ca2’]frec with 
either 0.2 mM (o--0) or 0.4 mM (A-A) PI. 
4. Discussion 
We report here evidence that human platelets con- 
tain a soluble, C!a2’-dependent PI phosphodiesterase. 
Most of the mammalian phospholipases C described 
so far are cytosolic [16,23,24] or membrane-bound 
[ZS] and require Ca2* for activity. A second group 
of PI phosphodiesterases of lysosomal origin possesses 
more acidic optimal pH and is not inhibited by EDTA 
[26]. From this study, it is evident that the platelet 
phosphoIipase C belongs to the former group. Further- 
more, the enzyme is almost totally soluble upon cell 
lysis. It should be noted that 90% of lactate 
dchydrogenase, a cytoplasmic marker, and only 10% 
of ~-acetyl-~-D-glLlcosaininidase, a lysosomal marker, 
are solubilized by our lysis procedure [27]. So the 
platelet enzyme might be exclusively located in the 
cytosol. 
The presence of such an enzyme in platelet 
cytosol might explain the phosphatidic acid produc- 
tion occurring in stimulated platelets [4-71. But the 
mechanism by which the enzyme could be activated 
remains still unknown. A role for a raised cytoplasmic 
Ca2’ concentration during the course of platelet 
activation could be questioned. However, like in 
other cells [ZS] , physiological agents are more 
efficient tltan Ca2’ ionophore in triggering phos- 
phatidic acid production by platelets [7]. In this case, 
the phosphatidic acid accumulation could precede the 
369 
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Ca2+ availability, since this phospholipid has been 
reported to behave as a Ca2’ ionophore [29,30]. 
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